Real-world Use Supports Effectiveness of Advate, Adynovate, and Feiba, Takeda Data Show
Takeda presented new real-world data highlighting the underdiagnosis of hemophilia A and B, supporting the effectiveness and safety of its…
Articles by Ana Pena, PhD
Catalyst Presents Positive Data of Under-the-Skin Candidate Therapies for Preventing, Treating Bleeds
Catalyst Biosciences has announced new clinical data supporting the safety and efficacy of its lead candidate therapies…
MRI Superior to Radiography in Capturing Joint Changes That Signal Future Bleeds, Study Says
Joint changes detected by magnetic resonance imaging (MRI), and often are missed on radiographs, are a strong predictor of…
First Child with Hemophilia B Dosed in Phase 4 Trial to Extend Ixinity to Those Under Age 12
Aptevo Therapeutics announced the dosing of a first patient in a Phase 4 study aiming to extend use of…
Prophylactic Use by Younger Patients Depends on Responsibility and Risk Estimates, Study Finds
The likelihood that teenagers and young adults with hemophilia will use a prophylactic replacement therapy as prescribed is mostly influenced by…
Risk of Inhibitors with Nuwiq Similar to Plasma-derived Products in Untreated Hemophilia A Patients, Trial Shows
Adults and children with severe hemophilia A who are receiving Nuwiq (recombinant human coagulation factor VIII) as their…
Takeda Presents Real-World Data on Cost-Effectiveness and Long-term Benefits of Adynovate and Feiba
Takeda has presented new real-world data to support the cost-effectiveness and persistent benefits to patients of its hemophilia…
Takeda Presents Early Data About Improving Efficiency of Hemophilia A and B Gene Therapy
Takeda has presented early data on the prevalence of — and a possible solution for — one of gene therapy’s…
New Early Data Support Catalyst’s MarzAA in Treating Acute Bleeds in Hemophilia
New preclinical data on one of Catalyst Biosciences’ lead candidate therapies — marzeptacog alfa activated (MarzAA), an engineered clotting Factor VIIa…
Enzyre and Takeda to Develop Coagulation Test that Patients Can Use at Home
Enzyre is teaming up with Takeda to develop a diagnostic device that will allow people with hemophilia…